SPONSOR
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Total Trials
5
Recruiting
5
Phases
Phase 4
Conditions studied: Endometrial CancerNon Small Cell Lung CancerLung Cancer MetastaticLung Cancer, Nonsmall CellLung AdenocarcinomaCervical Intraepithelial NeoplasiaMelanomaBreast CancerRenal Cell CarcinomaUrinary Bladder Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Endometrial Cancer, Non Small Cell Lung Cancer, Lung Cancer Metastatic, Lung Cancer, Nonsmall Cell.
The trial portfolio spans Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
How many clinical trials has Fondazione IRCCS Istituto Nazionale dei Tumori, Milano sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, of which 5 are actively recruiting participants. These trials cover conditions including Endometrial Cancer, Non Small Cell Lung Cancer, Lung Cancer Metastatic. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fondazione IRCCS Istituto Nazionale dei Tumori, Milano research focus on?
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano clinical trials span Endometrial Cancer, Non Small Cell Lung Cancer, Lung Cancer Metastatic, Lung Cancer, Nonsmall Cell, Lung Adenocarcinoma, and additional conditions. The research pipeline includes Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fondazione IRCCS Istituto Nazionale dei Tumori, Milano clinical trial?
To participate in a Fondazione IRCCS Istituto Nazionale dei Tumori, Milano trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fondazione IRCCS Istituto Nazionale dei Tumori, Milano trials with current recruitment status updated daily.
Clinical Trials by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
NCT06726291 Phase 4
Recruiting
Akynzeo as Antiemetic Treatment in Patients With Endometrial Cancer
Endometrial Cancer
NCT05537922
Recruiting
I3LUNG: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy
Non Small Cell Lung Cancer
NCT06611020
Recruiting
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
Cervical Intraepithelial Neoplasia
NCT05621837
Recruiting
Quantifying Systemic Immunosuppression to Personalize Cancer Therapy
Melanoma
NCT06361784
Recruiting
Improving the Success Rate for Thoracic Radiotherapy Through Specific Cardiac Substructure Dosimetry: Location Matters. (LOCATION MATTERS)
Locally Advanced Lung Non-Small Cell Carcinoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology